Tilray in Ireland
Tilray is one of the leading global companies in the research and production of medicinal cannabis. Our medicinal cannabis products have been authorized by the Irish Ministry of Health and are already available in Ireland on prescription. Our products have been accepted for use for qualifying patients under the Medical Cannabis Access Programme (MCAP). Under the MCAP, cannabis-based medicinal products can be prescribed by a consultant physician for three defined medical conditions, namely, chemotherapy-induced nausea and vomiting, spasticity associated with multiple sclerosis or severe, refractory epilepsy. Eligible patients must have their name entered on the cannabis for medical use register and should speak to their physician. For more information, please contact us.
Since 2019, Tilray has manufactured medicinal cannabis pharmaceuticals within Europe. Our GMP-certified cultivation and production facility in Portugal is among the most advanced in the world.
